The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and is a well-established biomarker for cardiovascular health. Its direct role in blood sugar regulation is less clear. Some observational and small intervention studies suggest that higher omega-3 intake (especially DHA) may improve insulin sensitivity and slightly lower fasting glucose. However, evidence is inconsistent: other studies found no significant effect or even a slight increase in blood glucose with very high doses. The Omega-3 Index should not be used as a standalone marker for glycemic control. It is more an indicator of overall cardiometabolic risk. In individuals with diabetes or prediabetes, a low Omega-3 Index may signal increased risk for cardiovascular complications, but a direct causal role on blood sugar is not established. High doses of omega-3s (>3 g/day) can affect blood clotting, so caution is warranted when taking anticoagulants. Overall, the evidence remains mixed, and individual recommendations should be based on comprehensive risk assessment.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-90b8d6929ca3c92c75054c8f